Cartesian Therapeutics, Inc.
RNAC$109M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaFREDERICK66 employees
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
3
Next Catalyst
Aug 6, 2026
6wMarket Overview
Stock performance and key metrics
RNAC News
Catalyst Timeline
3 upcoming, 0 past
Drug Pipeline
Decartes-08
Myasthaenia Gravis
Descartes-08
Systemic Lupus Erythematosus (SLE)
Descartes 11
Multiple Myeloma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Decartes-08 | Phase 3 | Myasthaenia Gravis | - | - |
Descartes-08 | Phase 2 | Systemic Lupus Erythematosus (SLE) | - | - |
Descartes 11 | Phase 2 | Multiple Myeloma | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply